Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
After the completion of the 251(g) process, EMGE will undergo an exchange for KOAN shares. I eagerly await news akin to the VVPR merger share exchange. The announcement today regarding VVPR share exchange sparked a +400% surge in share price. EMGE, characterized by its low float and absence of dilution, presents the potential for us to emulate such a scenario with our own low-float stock.
You may want to reassess the company once more. The outstanding shares have remained unchanged for the past 10 months, and now Zimbler no longer holds the controlling vote.
$EMGE TRIANGULAR MERGER DUE DILIGENCE UPDATE.
$EMGE On March 7, 2024, Resonate Blends, now known as KOAN, issued an 8-K entry into a Material Definitive Agreement, marking the execution of the triangular merger. KOAN, rebranded as Apollo, serves as the main parent company. Trading of KOAN and EMGE common shares will proceed as usual until the completion of the 251(g) reorganization of the new entity, Apollo. Following the conclusion of the 251(g) process, EMGE common shares will be exchanged for KOAN shares, and the company, now under parent company APOLLO, will undergo a name change through an official amendment to its name.
What makes this merger exceptional is NO reverse splits, the elimination of debts, and insider shares locked up for one year. On top of that, EMGE current float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is super rare in the realm of OTC land.
Let's now closely examine the subsidiaries of APOLLO BioWellness.
1 - EVOLUTIONARY BIOLOGICSIS Must see beautiful site: <><><> https://evolutionarybiologics.com/
In my humble opinion, it's evident that Morrison has all his ducks in a row, and it's only a matter of time before he launches a massive news campaign. Here's the proof: On September 12, 2023, (NASDAQ: BRTX) entered into a supply agreement with Evolutionary Biologics.
https://www.globenewswire.com/en/news-release/2023/09/12/2741711/0/en/BioRestorative-Therapies-Enters-into-Supply-Agreement-with-Evolutionary-Biologics.html
Additionally, he has the Cinema ads campaign ready for marketing Biologics products once the 251(g) process is completed. He organizes everything year in advance. His commitment to investing in product development and the Cinema ads campaign without diluting shares demonstrates his dedication to his companies and the shareholders. Such situations are beyond rare on the OTC land.
Watch the CINEMA ads Campaigns. Compelling and Essential Viewing: A Must-Watch Experience
https://apollobiowellness.com/on-demand-content/
$EMGE TRIANGULAR MERGER DUE DILIGENCE UPDATE.
$EMGE On March 7, 2024, Resonate Blends, now known as KOAN, issued an 8-K entry into a Material Definitive Agreement, marking the execution of the triangular merger. KOAN, rebranded as Apollo, serves as the main parent company. Trading of KOAN and EMGE common shares will proceed as usual until the completion of the 251(g) reorganization of the new entity, Apollo. Following the conclusion of the 251(g) process, EMGE common shares will be exchanged for KOAN shares, and the company, now under parent company APOLLO, will undergo a name change through an official amendment to its name.
What makes this merger exceptional is NO reverse splits, the elimination of debts, and insider shares locked up for one year. On top of that, EMGE current float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is super rare in the realm of OTC land.
Let's now closely examine the subsidiaries of APOLLO BioWellness.
1 - EVOLUTIONARY BIOLOGICSIS Must see beautiful site: <><><> https://evolutionarybiologics.com/
In my humble opinion, it's evident that Morrison has all his ducks in a row, and it's only a matter of time before he launches a massive news campaign. Here's the proof: On September 12, 2023, (NASDAQ: BRTX) entered into a supply agreement with Evolutionary Biologics.
https://www.globenewswire.com/en/news-release/2023/09/12/2741711/0/en/BioRestorative-Therapies-Enters-into-Supply-Agreement-with-Evolutionary-Biologics.html
Additionally, he has the Cinema ads campaign ready for marketing Biologics products once the 251(g) process is completed. He organizes everything year in advance. His commitment to investing in product development and the Cinema ads campaign without diluting shares demonstrates his dedication to his companies and the shareholders. Such situations are beyond rare on the OTC land.
Watch the CINEMA ads Campaigns. Compelling and Essential Viewing: A Must-Watch Experience
https://apollobiowellness.com/on-demand-content/
$EMGE TRIANGULAR MERGER DUE DILIGENCE UPDATE.
$EMGE On March 7, 2024, Resonate Blends, now known as KOAN, issued an 8-K entry into a Material Definitive Agreement, marking the execution of the triangular merger. KOAN, rebranded as Apollo, serves as the main parent company. Trading of KOAN and EMGE common shares will proceed as usual until the completion of the 251(g) reorganization of the new entity, Apollo. Following the conclusion of the 251(g) process, EMGE common shares will be exchanged for KOAN shares, and the company, now under parent company APOLLO, will undergo a name change through an official amendment to its name.
What makes this merger exceptional is NO reverse splits, the elimination of debts, and insider shares locked up for one year. On top of that, EMGE current float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is super rare in the realm of OTC land.
Let's now closely examine the subsidiaries of APOLLO BioWellness.
1 - EVOLUTIONARY BIOLOGICSIS Must see beautiful site: <><><> https://evolutionarybiologics.com/
In my humble opinion, it's evident that Morrison has all his ducks in a row, and it's only a matter of time before he launches a massive news campaign. Here's the proof: On September 12, 2023, (NASDAQ: BRTX) entered into a supply agreement with Evolutionary Biologics.
https://www.globenewswire.com/en/news-release/2023/09/12/2741711/0/en/BioRestorative-Therapies-Enters-into-Supply-Agreement-with-Evolutionary-Biologics.html
Additionally, he has the Cinema ads campaign ready for marketing Biologics products once the 251(g) process is completed. He organizes everything year in advance. His commitment to investing in product development and the Cinema ads campaign without diluting shares demonstrates his dedication to his companies and the shareholders. Such situations are beyond rare on the OTC land.
Watch the CINEMA ads Campaigns. Compelling and Essential Viewing: A Must-Watch Experience
https://apollobiowellness.com/on-demand-content/
Lisa won't announce anything until she's bought the shares. But since she's not making any purchases, I'm willing to bet that nothing will happen, at least not for the time being.
I think the question you want to ask me is how well Delaware using 251G benefits EMGE common shares.?
251(g) Reorganization: Section 251(g) of the Delaware General Corporation Law (DGCL) allows for certain types of mergers where two or more corporations consolidate or merge into a single corporation.
The Delaware 251(g) Reverse Triangular Merger involves the acquiring company (KOAN/APOLLO) establishing a subsidiary (New Parent Company) in Delaware, which then merges with the target company (EMGE). This results in EMGE becoming a subsidiary of the New Parent Company, EMGE's assets transferred to the New Parent Company, and EMGE ceases to exist as a separate entity.
This structure allows for a smooth transition of assets and ceases Series F Convertible Preferred Stock eliminated 93% of the diluted EMGE shares, while also providing certain legal and tax advantages, including the ability to absolve debts from merged subsidiaries and take advantage of Delaware's favorable tax laws.
Your due diligence is essentially outdated; CNGT, The Wholistic Company, is a subsidiary of EMGE, Both companies are run by Zimbler, not by Jim Morrison!
The issue with EMGE and CNGT stemmed from Jim Zimbler's influence. Zimbler had attempted to offer Morrison CNGT for years, but Morrison declined and eventually resigned as CEO and chairman.
$EMGE TRIANGULAR MERGER DUE DILIGENCE UPDATE.
$EMGE On March 7, 2024, Resonate Blends, now known as KOAN, issued an 8-K entry into a Material Definitive Agreement, marking the execution of the triangular merger. KOAN, rebranded as Apollo, serves as the main parent company. Trading of KOAN and EMGE common shares will proceed as usual until the completion of the 251(g) reorganization of the new entity, Apollo. Following the conclusion of the 251(g) process, EMGE common shares will be exchanged for KOAN shares, and the company, now under parent company APOLLO, will undergo a name change through an official amendment to its name.
What makes this merger exceptional is NO reverse splits, the elimination of debts, and insider shares locked up for one year. On top of that, EMGE current float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is super rare in the realm of OTC land.
Let's now closely examine the subsidiaries of APOLLO BioWellness.
1 - EVOLUTIONARY BIOLOGICSIS Must see beautiful site: <><><> https://evolutionarybiologics.com/
In my humble opinion, it's evident that Morrison has all his ducks in a row, and it's only a matter of time before he launches a massive news campaign. Here's the proof: On September 12, 2023, (NASDAQ: BRTX) entered into a supply agreement with Evolutionary Biologics.
https://www.globenewswire.com/en/news-release/2023/09/12/2741711/0/en/BioRestorative-Therapies-Enters-into-Supply-Agreement-with-Evolutionary-Biologics.html
Additionally, he has the Cinema ads campaign ready for marketing Biologics products once the 251(g) process is completed. He organizes everything year in advance. His commitment to investing in product development and the Cinema ads campaign without diluting shares demonstrates his dedication to his companies and the shareholders. Such situations are beyond rare on the OTC land.
Watch the CINEMA ads Campaigns. Compelling and Essential Viewing: A Must-Watch Experience
https://apollobiowellness.com/on-demand-content/
$EMGE TRIANGULAR MERGER DUE DILIGENCE UPDATE.
$EMGE On March 7, 2024, Resonate Blends, now known as KOAN, issued an 8-K entry into a Material Definitive Agreement, marking the execution of the triangular merger. KOAN, rebranded as Apollo, serves as the main parent company. Trading of KOAN and EMGE common shares will proceed as usual until the completion of the 251(g) reorganization of the new entity, Apollo. Following the conclusion of the 251(g) process, EMGE common shares will be exchanged for KOAN shares, and the company, now under parent company APOLLO, will undergo a name change through an official amendment to its name.
What makes this merger exceptional is NO reverse splits, the elimination of debts, and insider shares locked up for one year. On top of that, EMGE current float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is super rare in the realm of OTC land.
Let's now closely examine the subsidiaries of APOLLO BioWellness.
1 - EVOLUTIONARY BIOLOGICSIS Must see beautiful site: <><><> https://evolutionarybiologics.com/
In my humble opinion, it's evident that Morrison has all his ducks in a row, and it's only a matter of time before he launches a massive news campaign. Here's the proof: On September 12, 2023, (NASDAQ: BRTX) entered into a supply agreement with Evolutionary Biologics.
https://www.globenewswire.com/en/news-release/2023/09/12/2741711/0/en/BioRestorative-Therapies-Enters-into-Supply-Agreement-with-Evolutionary-Biologics.html
Additionally, he has the Cinema ads campaign ready for marketing Biologics products once the 251(g) process is completed. He organizes everything year in advance. His commitment to investing in product development and the Cinema ads campaign without diluting shares demonstrates his dedication to his companies and the shareholders. Such situations are beyond rare on the OTC land.
Watch the CINEMA ads Campaigns. Compelling and Essential Viewing: A Must-Watch Experience
https://apollobiowellness.com/on-demand-content/
$EMGE TRIANGULAR MERGER DUE DILIGENCE UPDATE.
$EMGE On March 7, 2024, Resonate Blends, now known as KOAN, issued an 8-K entry into a Material Definitive Agreement, marking the execution of the triangular merger. KOAN, rebranded as Apollo, serves as the main parent company. Trading of KOAN and EMGE common shares will proceed as usual until the completion of the 251(g) reorganization of the new entity, Apollo. Following the conclusion of the 251(g) process, EMGE common shares will be exchanged for KOAN shares, and the company, now under parent company APOLLO, will undergo a name change through an official amendment to its name.
What makes this merger exceptional is NO reverse splits, the elimination of debts, and insider shares locked up for one year. On top of that, EMGE current float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is super rare in the realm of OTC land.
Let's now closely examine the subsidiaries of APOLLO BioWellness.
1 - EVOLUTIONARY BIOLOGICSIS Must see beautiful site: <><><> https://evolutionarybiologics.com/
In my humble opinion, it's evident that Morrison has all his ducks in a row, and it's only a matter of time before he launches a massive news campaign. Here's the proof: On September 12, 2023, (NASDAQ: BRTX) entered into a supply agreement with Evolutionary Biologics.
https://www.globenewswire.com/en/news-release/2023/09/12/2741711/0/en/BioRestorative-Therapies-Enters-into-Supply-Agreement-with-Evolutionary-Biologics.html
Additionally, he has the Cinema ads campaign ready for marketing Biologics products once the 251(g) process is completed. He organizes everything year in advance. His commitment to investing in product development and the Cinema ads campaign without diluting shares demonstrates his dedication to his companies and the shareholders. Such situations are beyond rare on the OTC land.
Watch the CINEMA ads Campaigns. Compelling and Essential Viewing: A Must-Watch Experience
https://apollobiowellness.com/on-demand-content/
Look like it is reaching the bottom. .008
The §251 process would result in EMGE and KOAN becoming subsidiaries of a new entity holding company, Apollo. Pay attention to what it stated "All obligations of each subsidiary shall, therefore, be at the subsidiary level and not at the public company level;"
Page 2
EMGE, KOAN, AND APOLLO Have completed a reverse triangular merger. Right now, they are operating as separate entities until the completion of the 251(g) reorganization of the new company APOLLO. Once the 251(g) process is completed. EMGE will be exchanged for KOAN shares. EMGE and KOAN become the subsidiaries of APOLLO BioWellness. APOLLO, will undergo a name change. On the filings, they stated the name change normally that goes with the symbol change as well.
No, you know a lot more than most here.
It's a reverse triangular merger, and the completion of the 251(g) reorganization is anticipated to occur within a few weeks.
A tenfold increase to $0.018 seems easily doable. Considering the JUVENTIC subsidiary's revenue of $9 million valued at $0.09 per share,
$EMGE TRIANGULAR MERGER DUE DILIGENCE UPDATE.
$EMGE On March 7, 2024, Resonate Blends, now known as KOAN, issued an 8-K entry into a Material Definitive Agreement, marking the execution of the triangular merger. KOAN, rebranded as Apollo, serves as the main parent company. Trading of KOAN and EMGE common shares will proceed as usual until the completion of the 251(g) reorganization of the new entity, Apollo. Following the conclusion of the 251(g) process, EMGE common shares will be exchanged for KOAN shares, and the company, now under parent company APOLLO, will undergo a name change through an official amendment to its name.
What makes this merger exceptional is NO reverse splits, the elimination of debts, and insider shares locked up for one year. On top of that, EMGE current float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is super rare in the realm of OTC land.
Let's now closely examine the subsidiaries of APOLLO BioWellness.
1 - EVOLUTIONARY BIOLOGICSIS Must see beautiful site: <><><> https://evolutionarybiologics.com/
In my humble opinion, it's evident that Morrison has all his ducks in a row, and it's only a matter of time before he launches a massive news campaign. Here's the proof: On September 12, 2023, (NASDAQ: BRTX) entered into a supply agreement with Evolutionary Biologics.
https://www.globenewswire.com/en/news-release/2023/09/12/2741711/0/en/BioRestorative-Therapies-Enters-into-Supply-Agreement-with-Evolutionary-Biologics.html
Additionally, he has the Cinema ads campaign ready for marketing Biologics products once the 251(g) process is completed. He organizes everything year in advance. His commitment to investing in product development and the Cinema ads campaign without diluting shares demonstrates his dedication to his companies and the shareholders. Such situations are beyond rare on the OTC land.
Watch the CINEMA ads Campaigns. Compelling and Essential Viewing: A Must-Watch Experience
https://apollobiowellness.com/on-demand-content/
$EMGE TRIANGULAR MERGER DUE DILIGENCE UPDATE.
$EMGE On March 7, 2024, Resonate Blends, now known as KOAN, issued an 8-K entry into a Material Definitive Agreement, marking the execution of the triangular merger. KOAN, rebranded as Apollo, serves as the main parent company. Trading of KOAN and EMGE common shares will proceed as usual until the completion of the 251(g) reorganization of the new entity, Apollo. Following the conclusion of the 251(g) process, EMGE common shares will be exchanged for KOAN shares, and the company, now under parent company APOLLO, will undergo a name change through an official amendment to its name.
What makes this merger exceptional is NO reverse splits, the elimination of debts, and insider shares locked up for one year. On top of that, EMGE current float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is super rare in the realm of OTC land.
Let's now closely examine the subsidiaries of APOLLO BioWellness.
1 - EVOLUTIONARY BIOLOGICSIS Must see beautiful site: <><><> https://evolutionarybiologics.com/
In my humble opinion, it's evident that Morrison has all his ducks in a row, and it's only a matter of time before he launches a massive news campaign. Here's the proof: On September 12, 2023, (NASDAQ: BRTX) entered into a supply agreement with Evolutionary Biologics.
https://www.globenewswire.com/en/news-release/2023/09/12/2741711/0/en/BioRestorative-Therapies-Enters-into-Supply-Agreement-with-Evolutionary-Biologics.html
Additionally, he has the Cinema ads campaign ready for marketing Biologics products once the 251(g) process is completed. He organizes everything year in advance. His commitment to investing in product development and the Cinema ads campaign without diluting shares demonstrates his dedication to his companies and the shareholders. Such situations are beyond rare on the OTC land.
Watch the CINEMA ads Campaigns. Compelling and Essential Viewing: A Must-Watch Experience
https://apollobiowellness.com/on-demand-content/
$EMGE TRIANGULAR MERGER DUE DILIGENCE UPDATE.
$EMGE On 03/07/2024, Resonate Blends, KOAN issued the 8-K Entry into a Material Definitive Agreement. The triangular merger has been executed. KOAN and EMGE common shares will continue their regular trading activity until the completion of the 251(g) reorganization of the new company, APOLLO. Once the 251(g) process is completed. EMGE common shares will be exchanged for KOAN shares, and the company, now under parent company APOLLO, will undergo a name change through an official amendment to its name.
What makes this merger exceptional is NO reverse splits, the elimination of debts, and insider shares locked up for one year. On top of that, EMGE current float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is super rare in the realm of OTC land.
Let's now closely examine the subsidiaries of APOLLO BioWellness.
1 - EVOLUTIONARY BIOLOGICSIS Must see beautiful site: <><><> https://evolutionarybiologics.com/
In my humble opinion, it's evident that Morrison has all his ducks in a row, and it's only a matter of time before he launches a massive news campaign. Here's the proof: On September 12, 2023, (NASDAQ: BRTX) entered into a supply agreement with Evolutionary Biologics.
https://www.globenewswire.com/en/news-release/2023/09/12/2741711/0/en/BioRestorative-Therapies-Enters-into-Supply-Agreement-with-Evolutionary-Biologics.html
Additionally, he has the Cinema ads campaign ready for marketing Biologics products once the 251(g) process is completed. He organizes everything year in advance. His commitment to investing in product development and the Cinema ads campaign without diluting shares demonstrates his dedication to his companies and the shareholders. Such situations are beyond rare on the OTC land.
Watch the CINEMA ads Campaigns. Compelling and Essential Viewing: A Must-Watch Experience
https://apollobiowellness.com/on-demand-content/
$EMGE HUGE $$$$$ TRIANGULAR MERGER DD...
$EMGE TRIANGULAR MERGER DUE DILIGENCE UPDATE.
$EMGE On 03/07/2024, Resonate Blends, KOAN issued the 8-K Entry into a Material Definitive Agreement. The triangular merger has been executed. KOAN, now known as Apollo, is the main parent company. KOAN and EMGE common shares will continue their regular trading activity until the completion of the 251(g) reorganization of the new company, Apollo. EMGE common shares will be exchanged for KOAN shares, and the company, now under the name Apollo, will introduce a new name and expect a new symbol.
Following the conclusion of the 251(g) process, EMGE common shares will be exchanged for KOAN shares, and the company, now under the name Apollo, will introduce a new name and expect a new symbol.
What makes this merger exceptional is NO reverse splits, the elimination of debts, and insider shares locked up for one year. On top of that, EMGE current float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is super rare in the realm of OTC land.
Let's now closely examine the subsidiaries of APOLLO BioWellness.
1 - EVOLUTIONARY BIOLOGICSIS Must see beautiful site: <><><> https://evolutionarybiologics.com/
In my humble opinion, it's evident that Morrison has all his ducks in a row, and it's only a matter of time before he launches a massive news campaign. Here's the proof: On September 12, 2023, (NASDAQ: BRTX) entered into a supply agreement with Evolutionary Biologics.
https://www.globenewswire.com/en/news-release/2023/09/12/2741711/0/en/BioRestorative-Therapies-Enters-into-Supply-Agreement-with-Evolutionary-Biologics.html
Additionally, he has the Cinema ads campaign ready for marketing Biologics products once the 251(g) process is completed. He organizes everything year in advance. His commitment to investing in product development and the Cinema ads campaign without diluting shares demonstrates his dedication to his companies and the shareholders. Such situations are beyond rare on the OTC land.
Watch the CINEMA ads Campaigns. Compelling and Essential Viewing: A Must-Watch Experience
https://apollobiowellness.com/on-demand-content/
$EMGE TRIANGULAR MERGER DUE DILIGENCE UPDATE.
$EMGE On 03/07/2024, Resonate Blends, KOAN issued the 8-K Entry into a Material Definitive Agreement. The triangular merger has been executed. KOAN, now known as Apollo, is the main parent company. KOAN and EMGE common shares will continue their regular trading activity until the completion of the 251(g) reorganization of the new company, Apollo. Once the 251(g) process is completed, KOAN and EMGE common shares will be exchanged for shares of Apollo, which will have a new name and expect a new symbol.
What makes this merger exceptional is NO reverse splits, the elimination of debts, and insider shares locked up for one year. On top of that, EMGE current float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is super rare in the realm of OTC land.
Let's now closely examine the subsidiaries of APOLLO BioWellness.
1 - EVOLUTIONARY BIOLOGICSIS Must see beautiful site: <><><> https://evolutionarybiologics.com/
In my humble opinion, it's evident that Morrison has all his ducks in a row, and it's only a matter of time before he launches a massive news campaign. Here's the proof: On September 12, 2023, (NASDAQ: BRTX) entered into a supply agreement with Evolutionary Biologics.
https://www.globenewswire.com/en/news-release/2023/09/12/2741711/0/en/BioRestorative-Therapies-Enters-into-Supply-Agreement-with-Evolutionary-Biologics.html
Additionally, he has the Cinema ads campaign ready for marketing Biologics products once the 251(g) process is completed. He organizes everything year in advance. His commitment to investing in product development and the Cinema ads campaign without diluting shares demonstrates his dedication to his companies and the shareholders. Such situations are beyond rare on the OTC land.
Watch the CINEMA ads Campaigns. Compelling and Essential Viewing: A Must-Watch Experience
https://apollobiowellness.com/on-demand-content/
$EMGE On March 7, 2024, Resonate Blends, now known as KOAN, issued an 8-K entry into a Material Definitive Agreement, marking the execution of the triangular merger. KOAN, rebranded as Apollo, serves as the main parent company. Trading of KOAN and EMGE common shares will proceed as usual until the completion of the 251(g) reorganization of the new entity, APOLLO. Following the conclusion of the 251(g) process, EMGE common shares will be exchanged for KOAN shares, and the company, now under the name Apollo, will introduce a new name and expect new symbol.
What makes this merger exceptional is NO reverse splits, the elimination of debts, and insider shares locked up for one year. On top of that, EMGE current float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is super rare in the realm of OTC land.
Let's now closely examine the subsidiaries of APOLLO BioWellness.
1 - EVOLUTIONARY BIOLOGICSIS Must see beautiful site: <><><> https://evolutionarybiologics.com/
In my humble opinion, it's evident that Morrison has all his ducks in a row, and it's only a matter of time before he launches a massive news campaign. Here's the proof: On September 12, 2023, (NASDAQ: BRTX) entered into a supply agreement with Evolutionary Biologics.
https://www.globenewswire.com/en/news-release/2023/09/12/2741711/0/en/BioRestorative-Therapies-Enters-into-Supply-Agreement-with-Evolutionary-Biologics.html
Additionally, he has the Cinema ads campaign ready for marketing Biologics products once the 251(g) process is completed. He organizes everything year in advance. His commitment to investing in product development and the Cinema ads campaign without diluting shares demonstrates his dedication to his companies and the shareholders. Such situations are beyond rare on the OTC land.
Watch the CINEMA ads Campaigns. Compelling and Essential Viewing: A Must-Watch Experience
https://apollobiowellness.com/on-demand-content/
$EMGE TRIANGULAR MERGER DUE DILIGENCE UPDATE.
$EMGE On 03/07/2024, Resonate Blends, KOAN issued the 8-K Entry into a Material Definitive Agreement. The triangular merger has been executed. KOAN, now known as Apollo, is the main parent company. KOAN and EMGE common shares will continue their regular trading activity until the completion of the 251(g) reorganization of the new company, Apollo. Once the 251(g) process is completed, KOAN and EMGE common shares will be exchanged for shares of Apollo, which will have a new name and expect a new symbol.
What makes this merger exceptional is NO reverse splits, the elimination of debts, and insider shares locked up for one year. On top of that, EMGE current float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is super rare in the realm of OTC land.
Let's now closely examine the subsidiaries of APOLLO BioWellness.
1 - EVOLUTIONARY BIOLOGICSIS Must see beautiful site: <><><> https://evolutionarybiologics.com/
In my humble opinion, it's evident that Morrison has all his ducks in a row, and it's only a matter of time before he launches a massive news campaign. Here's the proof: On September 12, 2023, (NASDAQ: BRTX) entered into a supply agreement with Evolutionary Biologics.
https://www.globenewswire.com/en/news-release/2023/09/12/2741711/0/en/BioRestorative-Therapies-Enters-into-Supply-Agreement-with-Evolutionary-Biologics.html
Additionally, he has the Cinema ads campaign ready for marketing Biologics products once the 251(g) process is completed. He organizes everything year in advance. His commitment to investing in product development and the Cinema ads campaign without diluting shares demonstrates his dedication to his companies and the shareholders. Such situations are beyond rare on the OTC land.
Watch the CINEMA ads Campaigns. Compelling and Essential Viewing: A Must-Watch Experience
https://apollobiowellness.com/on-demand-content/
$EMGE TRIANGULAR MERGER DUE DILIGENCE UPDATE.
$EMGE On 03/07/2024, Resonate Blends, KOAN issued the 8-K Entry into a Material Definitive Agreement. The triangular merger has been executed. KOAN, now known as Apollo, is the main parent company. KOAN and EMGE common shares will continue their regular trading activity until the completion of the 251(g) reorganization of the new company, Apollo. Once the 251(g) process is completed, KOAN and EMGE common shares will be exchanged for shares of Apollo, which will have a new name and expect a new symbol.
What makes this merger exceptional is NO reverse splits, the elimination of debts, and insider shares locked up for one year. On top of that, EMGE current float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is super rare in the realm of OTC land.
Let's now closely examine the subsidiaries of APOLLO BioWellness.
1 - EVOLUTIONARY BIOLOGICSIS Must see beautiful site: <><><> https://evolutionarybiologics.com/
In my humble opinion, it's evident that Morrison has all his ducks in a row, and it's only a matter of time before he launches a massive news campaign. Here's the proof: On September 12, 2023, (NASDAQ: BRTX) entered into a supply agreement with Evolutionary Biologics.
https://www.globenewswire.com/en/news-release/2023/09/12/2741711/0/en/BioRestorative-Therapies-Enters-into-Supply-Agreement-with-Evolutionary-Biologics.html
Additionally, he has the Cinema ads campaign ready for marketing Biologics products once the 251(g) process is completed. He organizes everything year in advance. His commitment to investing in product development and the Cinema ads campaign without diluting shares demonstrates his dedication to his companies and the shareholders. Such situations are beyond rare on the OTC land.
Watch the CINEMA ads Campaigns. Compelling and Essential Viewing: A Must-Watch Experience
https://apollobiowellness.com/on-demand-content/
On September 12, 2023, (NASDAQ: BRTX) entered into a supply agreement with Evolutionary Biologics.
https://www.globenewswire.com/en/news-release/2023/09/12/2741711/0/en/BioRestorative-Therapies-Enters-into-Supply-Agreement-with-Evolutionary-Biologics.html
Watch the CINEMA ads Campaigns. Compelling and Essential Viewing: A Must-Watch Experience. These are the ads when we launch Biologics products. It's so awesome I watch it a few times.
https://apollobiowellness.com/on-demand-content/
Redken and Matrix are well-known brands in the beauty and hair care industry. They are subsidiaries or divisions of larger companies that specialize in hair care products.
Redken is a brand owned by L'Oréal Group, a multinational beauty and cosmetics company. Morrison, engineered the acquisitions of Redken and Matrix, guiding the company through a period of unprecedented growth.
INTHEKNOW1 I appreciate the kind words. For the first time in my life, I have spent countless hours working on the due diligence. Watching Mr. Morrison's video, I can sense his humility and sincerity. I wonder, after 9 years, why he left L'Oréal. I think part of the reason is that he witnessed L'Oréal, Redken, and Matrix generating billions of dollars in revenue, and he wants to pursue his dream of achieving that level of income.
He aimed to create a new video every quarter, but he ceased doing so due to the failure of the previous merger with EMGE. Morrison, a leader with an outstanding track record, is determined to guide his company to bigger exchanges, and I do not doubt his ability to do so.
Yes, as the president of L’Oréal for nine years. The president is second in charge; the chief executive officer (CEO) is considered the highest-ranking officer in a company. L’Oréal is a French personal care company that has established itself as the world’s largest cosmetics company. Number of employees 88,000 (2019) As of 2022, L’Oréal holds the distinction of being the largest cosmetics and beauty company in the world. Revenues amounted to approximately 40 billion U.S. dollars. Financial performance continued in 2023, with annual revenue reaching $44.572 billion
https://www.loreal-finance.com/eng/news-release/2022-annual-results
$EMGE TRIANGULAR MERGER DUE DILIGENCE UPDATE.
$EMGE On 03/07/2024, Resonate Blends, KOAN issued the 8-K Entry into a Material Definitive Agreement. The triangular merger has been executed. KOAN, now known as Apollo, is the main parent company. KOAN and EMGE common shares will continue their regular trading activity until the completion of the 251(g) reorganization of the new company, Apollo. Once the 251(g) process is completed, KOAN and EMGE common shares will be exchanged for shares of Apollo, which will have a new name and expect a new symbol.
What makes this merger exceptional is NO reverse splits, the elimination of debts, and insider shares locked up for one year. On top of that, EMGE current float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is super rare in the realm of OTC land.
The key question that needs addressing is the fate of the EMGE common shareholders.
When we refer to “EMGE Equity Interests”, it refers to the transfer of ownership in EMGE. The ownership or financial stake in a company.
These are the common financial terms. Equity interest, interest, compound interest, liability interest...“EMGE Equity Interests” include both preferred and common shares. Furthermore, (EMGE Equity Interests) include common stock, preferred stock, bonds, warrants, and other financial instruments.
$EMGE TRIANGULAR MERGER DUE DILIGENCE UPDATE.
$EMGE On 03/07/2024, Resonate Blends, KOAN issued the 8-K Entry into a Material Definitive Agreement. The triangular merger has been executed. KOAN, now known as Apollo, is the main parent company. KOAN and EMGE common shares will continue their regular trading activity until the completion of the 251(g) reorganization of the new company, Apollo. Once the 251(g) process is completed, KOAN and EMGE common shares will be exchanged for shares of Apollo, which will have a new name and expect a new symbol.
What makes this merger exceptional is NO reverse splits, the elimination of debts, and insider shares locked up for one year. On top of that, EMGE current float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is super rare in the realm of OTC land.
The key question that needs addressing is the fate of the EMGE common shareholders.
When we refer to “EMGE Equity Interests”, it refers to the transfer of ownership in EMGE. The ownership or financial stake in a company.
These are the common financial terms. Equity interest, interest, compound interest, liability interest...“EMGE Equity Interests” include both preferred and common shares. Furthermore, (EMGE Equity Interests) include common stock, preferred stock, bonds, warrants, and other financial instruments.
$EMGE TRIANGULAR MERGER DUE DILIGENCE UPDATE.
$EMGE On 03/07/2024, Resonate Blends, KOAN issued the 8-K Entry into a Material Definitive Agreement. The triangular merger has been executed. KOAN, now known as Apollo, is the main parent company. KOAN and EMGE common shares will continue their regular trading activity until the completion of the 251(g) reorganization of the new company, Apollo. Once the 251(g) process is completed, KOAN and EMGE common shares will be exchanged for shares of Apollo, which will have a new name and expect a new symbol.
What makes this merger exceptional is NO reverse splits, the elimination of debts, and insider shares locked up for one year. On top of that, EMGE current float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is super rare in the realm of OTC land.
The key question that needs addressing is the fate of the EMGE common shareholders.
When we refer to “EMGE Equity Interests”, it refers to the transfer of ownership in EMGE. The ownership or financial stake in a company.
These are the common financial terms. Equity interest, interest, compound interest, liability interest...“EMGE Equity Interests” include both preferred and common shares. Furthermore, (EMGE Equity Interests) include common stock, preferred stock, bonds, warrants, and other financial instruments.
Who are the owners of the preferred shares? Do they also hold common stock? Let's not overlook what transpired on January 1, 2024, when all the Series C shares were converted into Common Stock. Additionally, insiders still retain 134,427,516 restricted common shares, which will be acquired from KOAN.
The Class A Preferred Shares have no dividend or conversion rights.
Series B Convertible Preferred Stock has no voting rights. Can be convertible into twenty (20) shares of the Company’s common stock
From EMGE quarter for the period ending: September 30, 2023.
Page 11 Effective January 1, 2024, all the preferred C has converted into shares of common stock.
In Section 1.02 (c), it describes the result of the exchange: KOAN shall acquire the EMGE Equity Interests.
These are the common financial terms. Equity interest, interest, compound interest...The keyword after Equity Interest is the word ALSO....people get confused because they don't fully understand finance languages.
When we refer to “EMGE Equity Interests”, it refers to the transfer of ownership in EMGE. The ownership or financial stake in a company. These interests include both preferred and common shares. These securities can include common stock, preferred stock, bonds, warrants, and other financial instruments.
Nutty investor Welcome aboard.
Roftflmao. That is a good one.